Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction-Reference-Cited by-同舟云学术

Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction

Published:2017-01 Issue: Volume:227 Page:272-277
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Sinning Christoph,Kempf Tibor,Schwarzl Michael,Lanfermann Simon,Ojeda Francisco,Schnabel Renate B.,Zengin Elvin,Wild Philipp S.,Lackner Karl-J.,Munzel Thomas,Blankenberg Stefan,Wollert Kai C.,Zeller Tanja,Westermann Dirk

Funder

German Heart Foundation/German Foundation of Heart Research

German Center of Cardiovascular Research

European Union Seventh Framework Programme

BiomarCaRE

Stiftung Rheinland Pfalz für Innovation

Boehringer Ingelheim GmbH

Philips GmbH

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Heart failure with preserved ejection fraction: a clinical dilemma;Komajda;Eur. Heart J.,2014

2. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND;Brouwers;Eur. Heart J.,2013

3. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction;van Veldhuisen;J. Am. Coll. Cardiol.,2013

4. Natriuretic Peptides in Heart Failure;Lin;Clin. Chem.,2014

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is growth differentiation factor-15 a useful biomarker for chronic heart failure across body size?;International Journal of Cardiology;2024-09

2. Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier;Journal of Clinical Medicine;2024-08-07

3. Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review;Heliyon;2024-08

4. Distribution characteristics and diagnostic value of TMAO and its precursors in HFpEF and HFrEF;2024-04-23

5. Role of NT-proBNP and lung ultrasound in diagnosing and classifying heart failure in a hospitalized oldest-old population: a cross-sectional study;BMC Geriatrics;2024-04-20